Sack­lers win im­mu­ni­ty from opi­oid law­suits as Pur­due Phar­ma is dis­solved in bank­rupt­cy set­tle­ment

Last year
People
Pharma

As­sem­bly Bio ditch­es he­pati­tis B drug on liv­er tox­i­c­i­ty con­cerns in mid-stage test

Last year
R&D

Scoop: In­spired by the late Tachi Ya­ma­da, Jim Wil­son launch­es new non­prof­it tar­get­ing un­der­served ul­tra-rare dis­eases

Last year
People
Pharma

Take­da slammed with sur­prise PhI­II fail­ure on 'break­through' blood can­cer drug, im­plod­ing launch plans

Last year
R&D

FDA warns of heart-re­lat­ed events, can­cer, blood clots, and death for JAK in­hibitors

Last year
FDA+

Ex­pand­ing on in­jectable schiz­o­phre­nia fran­chise, J&J se­cures nod for first twice-year­ly treat­ment

Last year
FDA+

Astel­las paus­es Au­den­tes' gene ther­a­py pro­gram again af­ter 'ab­nor­mal' liv­er tests in yet an­oth­er set­back

Last year
R&D
Cell/Gene Tx

Opin­ion: Time for Biden to ex­plain the po­lit­i­cal med­dling in Covid vac­cine re­views

Last year
FDA+

Mov­ing past a pa­tient death, Po­sei­da of­fers an ear­ly snap­shot of proof of ef­fi­ca­cy for a next-gen sol­id tu­mor CAR-T

Last year
R&D
Cell/Gene Tx

ARCH-backed George Church spin­out shuts down af­ter gene ther­a­py tech strug­gles in an­i­mal mod­els

Last year
Startups

J&J HIV shot fails, adding an­oth­er blow to decades-long ef­fort to curb epi­dem­ic

Last year
R&D

Un­der with­er­ing fire, Gala­pa­gos founder and CEO On­no van de Stolpe is ex­it­ing top post

Last year
People

Feng Zhang's lab de­vel­ops po­ten­tial break­through in RNA edit­ing de­liv­ery us­ing 'ul­tra­com­pact' ver­sions of Cas13

Last year
Discovery
Cell/Gene Tx

Re­im­burse­ment be­gins slow­ly for Bio­gen’s ex­pen­sive Alzheimer’s drug

Last year
Pharma

Founders of Tai­wanese biotech in­volved in steal­ing Genen­tech se­crets plead guilty to con­spir­a­cy

Last year
People
Pharma

Big mon­ey: Flag­ship's uber-plat­form play Laronde rakes in $440M to chase pro­gram­ma­ble 'eR­NA'

Last year
Financing
Cell/Gene Tx

The past and fu­ture of an­ti­bod­ies, as told through HIV; An­oth­er big phar­ma joins CD47 game; and more

Last year
Weekly

Re­gen­eron, GSK see mas­sive spike in Covid-19 mAb de­mand as US de­bates buy­ing more

Last year
Coronavirus

The Cas­sa­va saga con­tin­ues as test­ing part­ner de­nies prepar­ing taint­ed Alzheimer's da­ta

Last year
R&D

Ap­peals court sides with Gilead, Kite in CAR-T patent brawl, void­ing Bris­tol My­ers’ big $1.2B award

Last year
Pharma
Cell/Gene Tx

WuXi Bi­o­log­ics earns lo­cal nod for ex­pan­sion to grow­ing MA man­u­fac­tur­ing site

Last year
Manufacturing

Cipla re­opens South African man­u­fac­tur­ing site af­ter vi­o­lent protests

Last year
Manufacturing

Opin­ion: Pfiz­er vac­cine's 3-month full ap­proval, and less than 1-month sBLA OK — is the FDA's 'gold stan­dard' evolv­ing?

Last year
FDA+

Al­bert Bourla picks a new deal­mak­er to lead the hunt for more drugs to swell Pfiz­er’s pipeline

Last year
Deals
R&D
First page Previous page 114115116117118119120 Next page Last page